momelotinib,Ilginatinib
sierra oncology,Nippon Shinyaku
['momelotinib', '#mpn', 'mpnsm']
#asco22 #mpnsm pettit: momelotinib non-inferior to rux for spv and raises hgb. ilginatinib another selective jak2i under development, exhibits minimal myelosuppression (other than therapeutic effects in mf, of course). 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)